Effectiveness of a community-based integrated strategy to control soil-transmitted helminthiasis and clonorchiasis in the People's Republic of China.


Journal

Acta tropica
ISSN: 1873-6254
Titre abrégé: Acta Trop
Pays: Netherlands
ID NLM: 0370374

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 01 11 2018
revised: 02 08 2020
accepted: 03 08 2020
pubmed: 18 8 2020
medline: 13 5 2021
entrez: 18 8 2020
Statut: ppublish

Résumé

Soil-transmitted helminthiases (STHs) are caused by a group of intestinal nematode infections due to poor hygiene and environments, and clonorchiasis is a food-borne trematode (FBT) infection caused by ingestion of raw freshwater fish. Both are endemic in the People's Republic of China. To explore a suitable control strategy, integrated interventions were applied between 2007 and 2009 in ten pilot counties (eight for the STHs and two for clonorchiasis). Drug administration was used for treatment and complementary efforts to improve the situation based on health education, provision of clean water and sanitation were carried out. Significant achievements were gained as reflected by a drastic decrease in prevalence these infections were demonstrated. The overall prevalence of STHs and clonorchiasis decreased from 35.9% to 7.8% and from 41.4% to 7.0%, respectively. The reduction of prevalence and high cost-effectiveness were documented supporting large-scale application of this integrated intervention in China and elsewhere.

Identifiants

pubmed: 32805214
pii: S0001-706X(18)31374-3
doi: 10.1016/j.actatropica.2020.105650
pii:
doi:

Substances chimiques

Soil 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105650

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Auteurs

Ying-Dan Chen (YD)

National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai 200025, China; Key Laboratory of Parasite and Vector Biology, Ministry of Health, WHO Collaborating Centre for Tropical Diseases, Shanghai 200025, China.

Hua-Zhong Li (HZ)

Chinese Center for Disease Control and Prevention, Beijing 102206, China.

Long-Qi Xu (LQ)

National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai 200025, China; Key Laboratory of Parasite and Vector Biology, Ministry of Health, WHO Collaborating Centre for Tropical Diseases, Shanghai 200025, China.

Men-Bao Qian (MB)

National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai 200025, China; Key Laboratory of Parasite and Vector Biology, Ministry of Health, WHO Collaborating Centre for Tropical Diseases, Shanghai 200025, China.

Hong-Chun Tian (HC)

Sichuan Center for Disease Control and Prevention, Chengdu 610041, China.

Yue-Yi Fang (YY)

Guangdong Center for Disease Control and Prevention, Guangzhou 510300, China.

Chang-Hai Zhou (CH)

National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai 200025, China; Key Laboratory of Parasite and Vector Biology, Ministry of Health, WHO Collaborating Centre for Tropical Diseases, Shanghai 200025, China.

Zhuo Ji (Z)

Heilongjiang Center for Disease Control and Prevention, Haerbin 150030, China.

Zi-Jian Feng (ZJ)

Chinese Center for Disease Control and Prevention, Beijing 102206, China.

Meng Tang (M)

Danling Center for Disease Control and Prevention, Danling 620200, China.

Qun Li (Q)

Chinese Center for Disease Control and Prevention, Beijing 102206, China.

Yu Wang (Y)

Chinese Center for Disease Control and Prevention, Beijing 102206, China.

Robert Bergquist (R)

Ingerod, Brastad, Sweden.

Xiao-Nong Zhou (XN)

National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai 200025, China; Key Laboratory of Parasite and Vector Biology, Ministry of Health, WHO Collaborating Centre for Tropical Diseases, Shanghai 200025, China. Electronic address: zhouxn1@chinacdc.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH